Cures Act May Speed Approval of Stem Cell Therapies for MS and Other Diseases
The 21st Century Cures Act, recently signed into law by President Barack Obama, includes provisions that aim to speed up the process by whichĀ the U.S. Food and Drug Administration (FDA) reviewsĀ stem cell treatments for patients with degenerative diseases, such as multiple sclerosis, rheumatoid arthritis, and Parkinson’s disease. This act also…